The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1-modulated P53 activity
Open accessAbstract
Hepatitis B virus (HBV) causes chronic infection in about 350 million people worldwide. Given the important role of the most abundant liver-specific microRNA, miR-122, in hepatic function and liver pathology, here we investigated the potential role and mechanism of miR-122 in regulating HBV replication. We found that miR-122 expression in liver was significantly down-regulated in patients with HBV infection compared with healthy controls, and the miR-122 levels were negatively correlated with intrahepatic viral load and hepatic necroinflammation. The depletion of endogenous miR-122 by its antisense inhibitor led to enhanced HBV replication, whereas overexpression of miR-122 by transfection of mimic or its expression vector inhibited viral production. We next identified cyclin G1 as an miR-122 target from multiple candidate target genes that are involved in the regulation of HBV replication. Overexpression and knockdown studies both showed that cyclin G1 regulated viral replication in HBV transfected cells. We also observed that cyclin G1 expression was up-regulated in HBV-infected patients, and cyclin G1 levels were inversely associated with miR-122 expression in liver tissues. Using coimmunoprecipitation, a luciferase reporter system, and electrophoretic mobility shift assay, we further demonstrated that cyclin G1 specifically interacted with p53, and this interaction blocked the specific binding of p53 to HBV enhancer elements and simultaneously abrogated p53-mediated inhibition of HBV transcription. Finally, we show that miR-122 suppressed HBV replication in p53 wildtype cells but not in null isogenic cells. Conclusion: miR-122 down-regulates its target cyclin G1, and thus interrupts the interaction between cyclin G1 and p53 and abrogates p53-mediated inhibition of HBV replication. Our work shows that miR-122 down-regulation induced by HBV infection can impact HBV replication and possibly contribute to viral persistence and carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
Interferon modulation of cellular microRNAs as an antiviral mechanism
Pedersen, I. M., Cheng, G., Wieland, S., Volinia, S., Croce, C. M., Chisari, F. V., & David, M. (2007) · Nature · doi:10.1038/nature06205 · Cited by 849
Gramantieri, L., Ferracin, M., Fornari, F., Veronese, A., Sabbioni, S., Liu, C.-G., Calin, G. A., Giovannini, C., Ferrazzi, E., Grazi, G. L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4607 · Cited by 813
Chang, J., Nicolas, E., Marks, D., Sander, C., Lerro, A., Buendia, M. A., Xu, C., Mason, W. S., Moloshok, T., Bort, R., et al. (2004) · RNA Biology · doi:10.4161/rna.1.2.1066 · Cited by 811
microRNA-122 stimulates translation of hepatitis C virus RNA
Henke, J. I., Goergen, D., Zheng, J., Song, Y., Schüttler, C. G., Fehr, C., Jünemann, C., & Niepmann, M. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.244 · Cited by 679
Tsai, W.-C., Hsu, P. W.-C., Lai, T.-C., Chau, G.-Y., Lin, C.-W., Chen, C.-M., Lin, C.-D., Liao, Y.-L., Wang, J.-L., Chau, Y.-P., et al. (2009) · Hepatology · doi:10.1002/hep.22806 · Cited by 583
Bai, S., Nasser, M. W., Wang, B., Hsu, S.-H., Datta, J., Kutay, H., Yadav, A., Nuovo, G., Kumar, P., & Ghoshal, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016774 · Cited by 477
Mechanisms of HBV-related hepatocarcinogenesis
Neuveut, C., Wei, Y., & Buendia, M. A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.033 · Cited by 421
Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., Das, A., Lopes, A. R., Borrow, P., Williams, K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061287 · Cited by 421
Fornari, F., Gramantieri, L., Giovannini, C., Veronese, A., Ferracin, M., Sabbioni, S., Calin, G. A., Grazi, G. L., Croce, C. M., Tavolari, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4797 · Cited by 401
miR-122, a paradigm for the role of microRNAs in the liver
Girard, M., Jacquemin, E., Munnich, A., Lyonnet, S., & Henrion-Caude, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.019 · Cited by 375
Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications
Brown, B. D., & Naldini, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2628 · Cited by 336
Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122
Jangra, R. K., Yi, M., & Lemon, S. M. (2010) · Journal of Virology · doi:10.1128/jvi.00417-10 · Cited by 306
Sarasin-Filipowicz, M., Krol, J., Markiewicz, I., Heim, M. H., & Filipowicz, W. (2009) · Nature Medicine · doi:10.1038/nm.1902 · Cited by 304
Xu, H., He, J.-H., Xiao, Z.-D., Zhang, Q.-Q., Chen, Y.-Q., Zhou, H., & Qu, L.-H. (2010) · Hepatology · doi:10.1002/hep.23818 · Cited by 270
Self-citationLiver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells
Chang, J., Guo, J.-T., Jiang, D., Guo, H., Taylor, J. M., & Block, T. M. (2008) · Journal of Virology · doi:10.1128/jvi.02575-07 · Cited by 218
Cyclin G Recruits PP2A to Dephosphorylate Mdm2
Okamoto, K., Li, H., Jensen, M. R., Zhang, T., Taya, Y., Thorgeirsson, S. S., & Prives, C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00504-x · Cited by 215
Control of hepatitis B virus at the level of transcription
Quasdorff, M., & Protzer, U. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01315.x · Cited by 202
Wang, S.-H., Yeh, S.-H., Lin, W.-H., Wang, H.-Y., Chen, D.-S., & Chen, P.-J. (2009) · Hepatology · doi:10.1002/hep.23163 · Cited by 186
Self-citationTang, H., & McLachlan, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1841 · Cited by 183
Shan, Y., Zheng, J., Lambrecht, R. W., & Bonkovsky, H. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.002 · Cited by 165
Zeng, C., Wang, R., Li, D., Lin, X.-J., Wei, Q.-K., Yuan, Y., Wang, Q., Chen, W. L., & Zhuang, S. (2010) · Hepatology · doi:10.1002/hep.23875 · Cited by 150
miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV
Qiu, L., Fan, H., Jin, W., Zhao, B. L., Wang, Y., Ju, Y., Chen, L., Chen, Y., Duan, Z., & Meng, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.021 · Cited by 149
Self-citationHost Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire
Tan, A., Loggi, E., Boni, C., Chia, A., Gehring, A., Sastry, K. S., Goh, V., Fisicaro, P., Andreone, P., Brander, C., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01124-08 · Cited by 129
Shi, J., Fan, J., Wu, R. J., Gao, X., Zhang, L. R., Wang, H., & Farrell, G. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05531.x · Cited by 120
Norman, K., & Sarnow, P. (2009) · Journal of Virology · doi:10.1128/jvi.01156-09 · Cited by 103
Ori, A., Zauberman, A., Doitsh, G., Paran, N., Oren, M., & Shaul, Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.544 · Cited by 97
Enhancer I Predominance in Hepatitis B Virus Gene Expression
Doitsh, G., & Shaul, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1799-1808.2004 · Cited by 90
Efficacy of short‐term dexamethasone therapy in acute‐on‐chronic pre‐liver failure
Zhang, X., Li, J., You, J., Liu, Y., Peng, J., Zhang, H., Xu, B., & Mao, Q. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00740.x · Cited by 47
Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB
Lin, Y.-C., Hsu, E., & Ting, L. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01280.x · Cited by 40
A Role for the Cyclin Box in the Ubiquitin-Mediated Degradation of Cyclin G1
Piscopo, D. M., & Hinds, P. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6346 · Cited by 25
Buhlmann, S., Racek, T., Schwarz, A., Schaefer, S., & Pützer, B. M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.02.021 · Cited by 13
Cited by
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
miR-122 – A key factor and therapeutic target in liver disease
Bandiera, S., Pfeffer, S., Baumert, T. F., & Zeisel, M. B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.004 · Cited by 629
MicroRNA miR-21 Attenuates Human Cytomegalovirus Replication in Neural Cells by Targeting Cdc25a
Fu, Y.-R., Liu, X.-J., Li, X.-J., Shen, Z.-Z., Yang, B., Wu, C.-C., Li, J.-F., Miao, L.-F., Ye, H.-Q., Qiao, G.-H., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01740-14 · Cited by 69
Differences in serum microRNA profiles in hepatitis B and C virus infection
Akamatsu, S., Hayes, C. N., Tsuge, M., Miki, D., Akiyama, R., Abe, H., Ochi, H., Hiraga, N., Imamura, M., Takahashi, S., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2014.10.017 · Cited by 64
Metadata
- Authors
- Wang, S., Qiu, L., Yan, X., Jin, W., Wang, Y., Chen, L., Wu, E., Ye, X., Gao, G. F., Wang, F., Chen, Y., Duan, Z., & Meng, S.
- Venue
- Hepatology
- Published
- 2012-03
- Volume
- 55
- Issue
- 3
- Pages
- 730-741
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2094829945
- Cited by
- 259
- References
- 34
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.